Hyperparathyroidism

Last updated: November 01, 2022

Hyperparathyroidism

Final Exam Playlist

Final Exam Playlist

Acromegaly
Hypopituitarism
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Diabetes insipidus
Diabetes insipidus: Nursing process (ADPIE)
Diabetes insipidus and SIADH: Pathology review
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Hyperparathyroidism
Hypoparathyroidism
Adrenal insufficiency: Pathology review
Cushing syndrome
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome: Clinical
Skin cancer
Skin cancer: Clinical
Skin cancer: Pathology review
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Breast cancer
Breast cancer: Pathology review
Breast cancer: Clinical
Breast cancer: Nursing process (ADPIE)
Pancreatic cancer
Prostate cancer
Prostate disorders and cancer: Pathology review
Leukemias: Pathology review
Leukemia: Nursing process (ADPIE)
Leukemia: Clinical
Acute leukemia
Chronic leukemia
Lymphoma: Clinical
Lymphomas: Pathology review
Non-Hodgkin lymphoma
Hodgkin lymphoma
Ischemic stroke
Stroke: Clinical
Stroke volume, ejection fraction, and cardiac output
Stroke: Nursing process (ADPIE)
Meningitis
Meningitis: Nursing process (ADPIE)
Seizures: Pathology review
Seizures: Clinical
Seizure disorder: Nursing process (ADPIE)
Parkinson disease
Anti-parkinson medications
Parkinson disease: Nursing process (ADPIE)
Guillain-Barre syndrome
Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Treponema pallidum (Syphilis)
Sexually transmitted infections: Clinical
HIV (AIDS)
Chest trauma: Clinical
Pneumothorax: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Asthma
Asthma: Clinical
Asthma: Nursing process (ADPIE)
Pulmonary edema
Pulmonary embolism
Electrolyte disturbances: Pathology review
Angina pectoris
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Coronary artery disease: Pathology review
Heart failure
Heart failure: Pathology review
Advanced cardiac life support (ACLS): Clinical
Chronic bronchitis
Peripheral vascular disease: Clinical
Peripheral arterial disease (PAD): Nursing process (ADPIE)
ECG basics
ECG normal sinus rhythm
Atrial flutter
Atrial fibrillation
Ventricular fibrillation
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
ECG cardiac infarction and ischemia
Peripheral venous disease (PVD): Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Age-related physiological changes: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)

Flashcards

Hyperparathyroidism

0 of 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 48-year-old female comes to her primary care PA for evaluation of fatigue and “diffuse pain in the bones.” Her symptoms started three months ago and have progressively worsened. Past medical history is notable for asthma and two kidney stones over the past three years, both of which passed spontaneously. She is uses an albuterol inhaler. Family history is notable for rheumatoid arthritis in her mother. The patient's vitals are within normal limits. Physical exam reveals intact strength and sensation in all extremities. Laboratory testing is ordered, and the results are as follows:

Laboratory value  Result 
 Serum sodium  140 mEq/L
 Serum potassium  4.5 mEq/L 
 Serum calcium  11.8 mg/dL  
 Serum phosphorus  2.5 mg/dL

Which of the following changes in bone structure would most likely be observed in this patient?

Transcript

Watch video only

With hyperparathyroidism, “hyper” refers to over, and “parathyroid” refers to the parathyroid glands, so hyperparathyroidism refers to a condition where there is an overproduction of parathyroid hormone.

Parathyroid hormone comes from the parathyroid glands which are buried within the thyroid gland, and their main job is to keep blood calcium levels stable.

Now, the majority of the extracellular calcium, the calcium in the blood and interstitium, is split almost equally between two groups - calcium that is diffusible and calcium that is not diffusible.

Diffusible calcium is small enough to diffuse across cell membranes and is separated into two subcategories.

The first is free-ionized calcium, which is involved in all sorts of cellular processes like neuronal action potentials, contraction of skeletal, smooth, and cardiac muscle, hormone secretion, and blood coagulation, all of which are tightly regulated by enzymes and hormones.

The second category is complexed calcium, which is where the positively charged calcium is ionically linked to tiny negatively charged molecules like oxalate, which is a small anion that are normally found in our blood in small amounts.

The complexed calcium forms a molecule that’s electrically neutral but unlike free-ionized calcium it’s not useful for cellular processes.

Both of these are called diffusible because they’re small enough to diffuse across cell membranes.

Finally there’s the non-diffusible calcium which is bound to negatively charged proteins like albumin.

The resulting protein-calcium complex is too large and charged to cross membranes, leaving this calcium also uninvolved in cellular processes.

Changes in the body’s levels of extracellular calcium are detected by a surface receptor in parathyroid cells that’s called the calcium-sensing receptor.

These changes affect the amount of parathyroid hormone that’s released by the parathyroid gland.

The parathyroid hormone gets the bones to release calcium, it gets the kidneys to reabsorb more calcium so it's not lost in the urine, and it synthesizes calcitriol, which is also known as 1,25-dihydroxycholecalciferol, or active vitamin D.

Active vitamin D then goes on to cause the gastrointestinal tract to increase calcium absorption.

Altogether, these effects help to keep the extracellular levels of calcium within a narrow range that’s between 8.5 to 10 mg/dl.

So there are three types of hyperparathyroidism - primary, secondary, and tertiary.

In primary hyperparathyroidism, the parathyroid gland is responsible for the problem, because it makes parathyroid hormone independently of the calcium level.

Excess parathyroid hormone stimulates osteoclasts to break down bone and makes the kidneys hold on to calcium and get rid of phosphate - resulting in hypercalcemia and hypophosphatemia.

The excess calcium makes neurons less excitable, which leads to slower muscle contractions, and diminishes neuron firing in the central nervous system.

It also causes hypercalciuria - excess loss of calcium in urine - which can lead to dehydration. This is because there is just too much calcium to be reabsorbed by the kidneys.

Most often, primary hyperparathyroidism is caused by a single parathyroid adenoma, or benign tumor, which happens either because of a genetic mutation in a single cell or because of an inherited disorder like multiple endocrine neoplasia, which affects the parathyroid, pancreas, and pituitary glands.

Rarely, primary hyperparathyroidism is caused by hyperplasia, where parathyroid cells divide excessively causing growth of the glands, or by a parathyroid carcinoma, a cancerous tumor.

In secondary hyperparathyroidism, the parathyroid gland is normal, but it makes excess parathyroid hormone in response to chronic hypocalcemia - a low level of calcium - from another cause.

Key Takeaways

Hyperparathyroidism is a condition in which the parathyroid glands produce too much parathyroid hormone (PTH), which regulates calcium levels in the blood. Hyperparathyroidism can be primary, secondary, or even tertiary.

Primary hyperparathyroidism usually results from PTH secretion by a parathyroid adenoma. It is characterized by excess PTH that leads to high blood calcium levels (hypercalcemia), bone mass loss, kidney stones, and other health problems, such as psychiatric issues.

Secondary hyperparathyroidism develops when there are conditions like chronic kidney disease, which can lead to low calcium, high phosphate, and low vitamin D levels. It is mainly characterized by osteodystrophy, in which there is bone weakening associated with bone pain and deformation.

Finally, there is tertiary hyperparathyroidism, which occurs because of chronic secondary hyperparathyroidism from kidney disease. This leads to hypercalcemia and phosphate imbalances.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications" Endocrine Reviews (2001)
  7. "Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients" Cochrane Database of Systematic Reviews (2014)